Atlas Trials

Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia

Clinical trial NCT02135874 · COMPLETED

Trial details

NCT number
NCT02135874
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Bilineal LeukemiaAcute Biphenotypic LeukemiaAcute Leukemia of Ambiguous LineageAcute Undifferentiated LeukemiaMixed Phenotype Acute LeukemiaMixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise SpecifiedMixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise SpecifiedRecurrent Mixed Phenotype Acute Leukemia
Start date
2014-10-27
Primary completion
2023-02-21
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.